MB-11362
MB-11362 is an orally active, selective HCV NS5B polymerase inhibitor and 4′-azidouridine triphosphate prodrug. MB-11362 can be converted to 4′-azidouridine triphosphate after oral administration. MB-11362 can be used in the research of HCV infection[1].
Product Specifications
Product Name Alternative
RG-7348
UNSPSC
12352005
Target
HCV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
CCC(O[C@H]1[C@@H](OC(CC)=O)[C@H](N2C(NC(C=C2)=O)=O)O[C@@]1(COP3(O[C@H](C4=CC(Cl)=CC=C4)CCO3)=O)N=[N+]=[N-])=O
Molecular Formula
C24H27ClN5O11P
Molecular Weight
627.92
References & Citations
[1]Coats SJ, et al. Chutes and ladders in hepatitis C nucleoside drug development. Antiviral Res. 2014 Feb;102:119-47.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-123186/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[1159183-97-7]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1158446-01 0.02 mg (E-Coli)
Recombinant Clostridium perfringens Uncharacterized protein CPE0190 (CPE0190)
Ask
View Details MBS1158446-02 0.1 mg (E-Coli)
Recombinant Clostridium perfringens Uncharacterized protein CPE0190 (CPE0190)
Ask
View Details